News from viking therapeutics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 17, 2021, 16:05 ET Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 10, 2021, 16:05 ET Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jan 06, 2021, 16:05 ET Viking Therapeutics Announces Senior Management Team Appointments

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jan 05, 2021, 16:05 ET Viking Therapeutics to Present at H.C. Wainwright BioConnect 2021 Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Nov 10, 2020, 16:05 ET Viking Therapeutics to Present at Stifel Healthcare Conference 2020

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Oct 28, 2020, 16:05 ET Viking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Oct 21, 2020, 16:05 ET Viking Therapeutics to Report Financial Results for Third Quarter 2020 on October 28, 2020

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Sep 09, 2020, 07:05 ET Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK0214

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Sep 02, 2020, 16:30 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Aug 28, 2020, 06:00 ET Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Aug 20, 2020, 07:30 ET Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jul 29, 2020, 16:05 ET Viking Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jul 28, 2020, 16:05 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jul 22, 2020, 16:05 ET Viking Therapeutics to Report Financial Results for Second Quarter 2020 on July 29, 2020

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

May 27, 2020, 07:30 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

May 12, 2020, 17:00 ET Viking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting

Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 30, 2020, 16:05 ET Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 28, 2020, 07:30 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 23, 2020, 07:30 ET Viking Therapeutics to Report Financial Results for First Quarter 2020 on April 30, 2020

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 07, 2020, 07:30 ET Viking Therapeutics to Participate in 19th Annual Needham Healthcare Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 26, 2020, 16:15 ET Viking Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 24, 2020, 07:30 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 19, 2020, 07:30 ET Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jan 06, 2020, 07:30 ET Viking Therapeutics to Present at Biotech Showcase 2020

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Nov 19, 2019, 07:05 ET Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...